sema + cagrilintide blend GLP-Cagri – Biostrategix CAGRISEMA | peptidesskin

What does the BPC-157 peptide do

In lab and clinical research, its been observed to activate fibroblasts (the cells that produce collagen), increase glycosaminoglycan synthesis (which helps skin retain water), modulate matrix metalloproteinases (MMPs, the enzymes that break down old tissue), and act as a copper cofactor in antioxidant pathways

H19, for instance, is upregulated in the decompensated right ventricle of PAH patients and is associated with right ventricular hypertrophy and fibrosis

But do they actually work

The standard therapeutic approach uses 0.5 mg daily, ideally split into two doses approximately 12 hours apart